ESTRATEST Trademark

Trademark Overview

On Thursday, September 14, 2017, a trademark application was filed for ESTRATEST with the United States Patent and Trademark Office. The USPTO has given the ESTRATEST trademark a serial number of 87608565. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 12, 2020. This trademark is owned by Method Pharmaceuticals, LLC.. The ESTRATEST trademark is filed in the Pharmaceutical Products category with the following description:

Male and Female Hormone Tablet; Hormone Replacement Therapy Preparations
estratest

General Information

Serial Number87608565
Word MarkESTRATEST
Filing DateThursday, September 14, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, February 12, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMale and Female Hormone Tablet; Hormone Replacement Therapy Preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMethod Pharmaceuticals, LLC.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFort Worth, TX 76244

Trademark Events

Event DateEvent Description
Wednesday, February 12, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, February 12, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 1, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 1, 2019INQUIRY TO SUSPENSION E-MAILED
Thursday, August 1, 2019SUSPENSION INQUIRY WRITTEN
Thursday, January 31, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 31, 2019LETTER OF SUSPENSION E-MAILED
Thursday, January 31, 2019SUSPENSION LETTER WRITTEN
Thursday, June 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 28, 2018NON-FINAL ACTION E-MAILED
Thursday, June 28, 2018NON-FINAL ACTION WRITTEN
Friday, June 15, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 15, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 12, 2018ASSIGNED TO LIE
Saturday, June 2, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, May 31, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 31, 2018PETITION TO REVIVE-GRANTED
Thursday, May 31, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, April 30, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, April 30, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, October 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 2, 2017NON-FINAL ACTION E-MAILED
Monday, October 2, 2017NON-FINAL ACTION WRITTEN
Monday, October 2, 2017ASSIGNED TO EXAMINER
Wednesday, September 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

estratest hormone therapy preparations replacement tablet female male